We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 980

My Lawyer Said It Was OK: ‘Scully’ and Defending Based on Reliance on Counsel
  • Morvillo Abramowitz Grand Iason & Anello PC
  • USA
  • April 3 2018

Good faith reliance on counsel can be a critical line of defense for the accused in white-collar referred to as the "involvement of counsel" defense


Enforcement and Litigation Strategies: Skadden’s Eighth Annual Pharmaceutical, Biotechnology and Medical Device Seminar
  • Skadden Arps Slate Meagher & Flom LLP
  • USA
  • March 29 2018

On March 15, 2018, Skadden hosted its Eighth Annual Pharmaceutical, Biotechnology and Medical Device Seminar in Palo Alto, California, which focused


YLD Health Law Committee - Winter 2018
  • Breazeale Sachse & Wilson LLP
  • USA
  • March 26 2018

Few things can ruin a day faster than having a federal investigative agent show up at the door. In the current climate in which the government


Something Rotten in Denmark? The International Criminalization of Drug Advertising
  • Morvillo Abramowitz Grand Iason & Anello PC
  • USA
  • February 20 2018

Sometimes, when it comes to drafting posts for The Insider, a little digging can turn up remarkable results. This week’s post demonstrates the point


Something Rotten in Denmark? The International Criminalization of Drug Advertising
  • Morvillo Abramowitz Grand Iason & Anello PC
  • USA, European Union
  • February 20 2018

Sometimes, when it comes to drafting posts for The Insider, a little digging can turn up remarkable results. This week’s post demonstrates the point


The State AG Report Weekly Update December 14, 2017
  • Cozen O'Connor
  • USA
  • December 14 2017

Republican state Representative Todd Atwater has declared his candidacy for South Carolina AG in 201


FDA Issues Warning to Four Companies Marketing Cannabidiol Containing Products as Anti-Cancer Treatment
  • FisherBroyles LLP
  • USA
  • November 6 2017

On November 1, 2017, the U.S. Food and Drug Administration issued warning letters to four companies that were illegally marketing and selling products


Inside the Courts - An Update From Skadden Securities Litigators
  • Skadden Arps Slate Meagher & Flom LLP
  • USA
  • November 5 2017

Judge Patti B. Saris denied the Bank of New York Mellon’s (BNY Mellon) motion to strike putative class representative Ashby Henderson. BNY Mellon


Insys Therapeutics Runs Afoul of Attorneys General in Two States
  • FisherBroyles LLP
  • USA
  • October 10 2017

Arizona-based pharmaceutical company Insys Therapeutics Inc. (Insys) has found itself under investigation in both Massachusetts and New Jersey over


Inside the Courts - An Update From Skadden Securities Litigators
  • Skadden Arps Slate Meagher & Flom LLP
  • USA
  • September 27 2017

The U.S. Supreme Court resolved a circuit split by deciding that the three-year limit for filing lawsuits under Section 13 of the Securities Act is a